Hypertension, a silent killer, is increasingly prevalent among India's working population, especially those in their 30s. Lifestyle factors like stress, poor diet, and sedentary habits contribute ...

Patients with untreated or uncontrolled hypertension who started antihypertensive monotherapy in the first month after diagnosis were more likely to achieve blood pressure (BP) control at 6 months ...

World Hypertension Day 2025: From narrowing of the arteries to passive smoking’s toxic effects, know all about smoking's link to hypertension here. World Hypertension Day 2025: Hypertension ...

Hypertension is one of these ailments that is now becoming an unfortunate norm among people. To focus on the impact of hypertension and finding solutions to treat it, World Hypertension Day is ...

Clinically defined as a systolic/diastolic blood pressure ≥140/90 mmHg, hypertension affects an estimated 1.4 billion adults aged 30–79 worldwide, with more men likely to have hypertension ...

May 17 is World Hypertension Day, a time to raise awareness about the silent yet serious condition of high blood pressure. Hypertension, aptly called slow killer, rarely shows obvious symptoms ...

Objective Hypertension is reported to be the most prevalent risk factor for cardiovascular disease in elite athletes. We aimed to review blood pressure (BP) and prevalence of hypertension in different ...

Other contributing risk factors include male gender, family history of hypertension, high salt intake, gestational age or birth weight, sedentary lifestyle, and poor dietary habits,” adds Dr ...

Hypothyroidism has been recognized as a cause of secondary hypertension. Previous studies on the prevalence of hypertension in subjects with hypothyroidism have demonstrated elevated blood ...

5 "Chlorthalidone has played a key role in hypertension treatment strategies for decades," said William B. White, M.D., Professor Emeritus at the University of Connecticut School of Medicine and ...

MANILA, Philippines — The Philippine economy expanded by 5.4% in the first quarter of 2025, according to the Philippine Statistics Authority (PSA) in a report released on Thursday, May 5.

Noninferiority trial favored amiloride as an alternative to spironolactone in lowering home systolic blood pressure (SBP) for people with resistant hypertension. Twelve weeks into the trial ...